Taylor A T, Pritchard D C, Goldstein A O, Fletcher J L
Department of Pharmacy Practice, University of Georgia College of Pharmacy, Athens.
J Fam Pract. 1994 Aug;39(2):182-5.
Interactions between warfarin and penicillins have been infrequently reported. A case report of a single patient who experienced the effects of a warfarin-nafcillin interaction as well as a warfarin-dicloxacillin interaction is presented. Clinical effects of this interaction were documented primarily through changes in prothrombin time (PT) and the need for higher warfarin dosing. While the patient received nafcillin, warfarin doses were increased to as much as 4.5 times the previous amounts needed to provide adequate anticoagulation. During dicloxacillin therapy, warfarin doses were gradually decreased, but stabilized to a maintenance dose higher than the patient's pre-nafcillin dose. The dicloxacillin-warfarin interaction appears similar to that noted during nafcillin-warfarin combination.
华法林与青霉素之间的相互作用鲜有报道。本文呈现了一例患者同时经历华法林-萘夫西林相互作用以及华法林-双氯西林相互作用的病例报告。这种相互作用的临床效应主要通过凝血酶原时间(PT)的变化以及更高华法林剂量需求来记录。当患者接受萘夫西林治疗时,华法林剂量增加至之前提供充分抗凝所需剂量的4.5倍之多。在双氯西林治疗期间,华法林剂量逐渐降低,但稳定在高于患者接受萘夫西林治疗前剂量的维持剂量。双氯西林-华法林相互作用似乎与萘夫西林-华法林联合使用时所观察到的相互作用相似。